Tizanidine
Product Images NDC 50436-6755

5 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-6755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A pharmacokinetic graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, showing concentration changes up to 24 hours post-dose.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph comparing the improvement in Ashworth score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis shows improvement in Ashworth score, and the x-axis represents hours post-dose from 0 to 6. Data points include error bars indicating variability.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A line graph showing improvement in Ashworth Score comparing tizanidine (mean dose 28.8 mg) and placebo at three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine shows greater improvement over placebo at each time point.*
FDA Label Image

Label Image (Lbl504366755)

Label Image (Lbl504366755)
Label for Tizanidine 2 mg tablets by Unit Dose Services, showing a package of 30 tablets. Label includes NDC 50436-6755-1, manufacturing details citing Dr. Reddy's, storage instructions, and placeholders for lot and expiration dates. The label also displays the Unit Dose Services address in Miami, FL.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Tizanidine hydrochloride, depicted as a molecular diagram showing its fused ring system and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.